SkinBioTherapeutics adds interim CEO Rachel Parsonage to board
SkinBioTherapeutics on Monday confirmed the appointment of Interim Chief Executive Officer Rachel Parsonage to its board after completing regulatory due diligence.
Parsonage was appointed as interim...
Mon, 09/03/2026 - 14:35